DNA Biomed Solns (DNA) - Total Liabilities

Latest as of June 2025: ILA1.77 Million ILA ≈ $4.76K USD

Based on the latest financial reports, DNA Biomed Solns (DNA) has total liabilities worth ILA1.77 Million ILA (≈ $4.76K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore DNA long-term investments to assets to see how much of total assets are deployed in long-term investments.

DNA Biomed Solns - Total Liabilities Trend (2005–2024)

This chart illustrates how DNA Biomed Solns's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see DNA Biomed Solns total assets.

DNA Biomed Solns Competitors by Total Liabilities

The table below lists competitors of DNA Biomed Solns ranked by their total liabilities.

Company	Country	Total Liabilities
JNK Heaters Co. Ltd KQ:126880	Korea	₩143.42 Billion
Indah Prakasa Sentosa PT Tbk JK:INPS	Indonesia	Rp283.96 Billion
Compal Broadband Networks Inc TW:6674	Taiwan	NT$325.30 Million
Orbit Garant Drilling Inc. TO:OGD	Canada	CA$79.27 Million
Beeline Holdings, Inc. NASDAQ:BLNE	USA	$19.35 Million
Plata Latina Minerals Corp V:PLA	Canada	CA$60.71K
Filana Therapeutics, Inc. NASDAQ:FLNA	USA	$40.29 Million
Dierig Holding AG XETRA:DIE	Germany	€76.08 Million

Liability Composition Analysis (2005–2024)

This chart breaks down DNA Biomed Solns's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See DNA net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	48.83	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DNA Biomed Solns's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DNA Biomed Solns (2005–2024)

The table below shows the annual total liabilities of DNA Biomed Solns from 2005 to 2024.

Year	Total Liabilities	Change
2024-12-31	ILA2.81 Million ≈ $7.55K	+91.37%
2023-12-31	ILA1.47 Million ≈ $3.94K	-21.84%
2022-12-31	ILA1.88 Million ≈ $5.05K	+555.75%
2021-12-31	ILA287.00K ≈ $769.44	-97.28%
2020-12-31	ILA10.54 Million ≈ $28.27K	+23.30%
2019-12-31	ILA8.55 Million ≈ $22.92K	-45.92%
2018-12-31	ILA15.81 Million ≈ $42.39K	+75.94%
2017-12-31	ILA8.99 Million ≈ $24.09K	-92.61%
2016-12-31	ILA121.59 Million ≈ $325.97K	+236.83%
2015-12-31	ILA36.10 Million ≈ $96.77K	+30.42%
2014-12-31	ILA27.68 Million ≈ $74.20K	+201.03%
2013-12-31	ILA9.19 Million ≈ $24.65K	-4.97%
2012-12-31	ILA9.68 Million ≈ $25.94K	+51.84%
2011-12-31	ILA6.37 Million ≈ $17.08K	-29.79%
2010-12-31	ILA9.08 Million ≈ $24.33K	+35.44%
2009-12-31	ILA6.70 Million ≈ $17.97K	-16.97%
2008-12-31	ILA8.07 Million ≈ $21.64K	+49.13%
2006-12-31	ILA5.41 Million ≈ $14.51K	+68.02%
2005-12-31	ILA3.22 Million ≈ $8.64K	--

About DNA Biomed Solns

TA:DNA Israel Biotechnology

Market Cap

$33.68 Million

ILA12.56 Billion ILA

Market Cap Rank

#23467 Global

#325 in Israel

Share Price

ILA102.00

Change (1 day)

-2.02%

52-Week Range

ILA86.00 - ILA147.50

All Time High

ILA1900.80